Novavax (United States)

Novavax (United States)

Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Novavax (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

82%


Total
Publications

262


Total Open
Publications

214


Total
Citations

11K


Open Access
Percentage

82%


Total
Publications

262


Total Open
Publications

214


Total
Citations

11K

Wikipedia

Website

download

Breakdown

17% 43% 22% 18%

Publisher Open

17%

Both

43%

Other Platform Open

22%

Closed

18%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

05101520253035404550Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

37%OA Journal

OA Journal 37%

58

Hybrid 46%

73

No Guarantees 17%

26

Other Platform Open

Domain 73%

124

Preprint 29%

50

Other Internet 22%

38

Institution 21%

35

Public 9%

15

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
127
Europe PMC
Domain
54
DOI
Other Internet
36
medRxiv
Preprint
29
bioRxiv
Preprint
13
Semantic Scholar
Public
12
Research Square
Preprint
9
St George's University of London - St George's Online Research Archive
Institution
7
University of Oxford - Oxford University Research Archive (ORA)
Institution
6
University of California - eScholarship University of California
Institution
5
1 / 5

Data updated 13 August 2024

Share

Share

Share